Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial | Researchclopedia
Back to research
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
2016
1,124 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
70.36
Yale University
Talia Golan
·
Sheba Medical Center
Dung T. Le
·
Johns Hopkins University
Barbara Burtness
·
Fox Chase Cancer Center
Autumn J. McRee
·
University of North Carolina at Chapel Hill
Chia‐Chi Lin
·
National Taiwan University Hospital
Kumudu Pathiraja
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Jared Lunceford
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Kenneth Emancipator
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Jonathan Juco
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Minori Koshiji
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Yung‐Jue Bang
·
Seoul National University